المؤلفون: Luigino Calzetta, Alfredo Chetta, Matteo Matino, Paola Rogliani, Beatrice Ludovica Ritondo, Angelo Coppola

المصدر: International Journal of COPD, Vol Volume 16, Pp 257-279 (2021)
International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Chemokine, Inflammation, Muscarinic Antagonists, Review, Pharmacology, law.invention, Contractility, Pulmonary Disease, Chronic Obstructive, Randomized controlled trial, tiotropium, systematic review, law, Muscarinic acetylcholine receptor, lama, Settore MED/10, medicine, Humans, Tiotropium Bromide, Submucosal glands, lcsh:RC705-779, COPD, muscarinic receptor antagonist, biology, business.industry, General Medicine, lcsh:Diseases of the respiratory system, medicine.disease, Receptors, Muscarinic, Bronchodilator Agents, respiratory tract diseases, inflammation, biology.protein, medicine.symptom, Airway, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d89ec8b782565ef4e544ac84ab0fd2e5Test
https://www.dovepress.com/the-impact-ofTest-muscarinic-receptor-antagonists-on-airway-inflammation-a-peer-reviewed-article-COPD

المؤلفون: Robert Fogel, Marc Miravitlles, Kenneth R. Chapman, Francesco Patalano, Konstantinos Kostikas, Nicolas Roche, Petter Olsson, Claus Vogelmeier, Jørgen Vestbo, Donald Banerji, Chau Thach, Jadwiga A. Wedzicha

المصدر: International Journal of COPD, Vol Volume 13, Pp 1125-1134 (2018)
Vogelmeier, C F, Chapman, K R, Miravitlles, M, Roche, N, Vestbo, J, Thach, C, Banerji, D, Fogel, R, Patalano, F, Olsson, P, Kostikas, K & Wedzicha, J A 2018, ' Exacerbation heterogeneity in COPD : Subgroup analyses from the FLAME study ', International Journal of COPD, vol. 13, pp. 1125-1134 . https://doi.org/10.2147/COPD.S160011Test
International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Time Factors, Exacerbation, Respiratory System, Vital Capacity, Kaplan-Meier Estimate, Quinolones, indacaterol/glycopyrronium, salmeterol/fluticasone, Rate ratio, Severity of Illness Index, DOUBLE-BLIND, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, exacerbation, Adrenal Cortex Hormones, Risk Factors, Forced Expiratory Volume, Odds Ratio, 030212 general & internal medicine, Lung, Original Research, Fluticasone, COPD, Health Policy, General Medicine, Middle Aged, Fluticasone-Salmeterol Drug Combination, LABA/ICS, Bronchodilator Agents, 3. Good health, LUNG-FUNCTION, Hospitalization, Drug Combinations, Treatment Outcome, Indans, Disease Progression, Female, Salmeterol, IND/GLY, Life Sciences & Biomedicine, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, PARALLEL-GROUP, animal structures, SFC, Subgroup analysis, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, OBSTRUCTIVE PULMONARY-DISEASE, SALMETEROL-FLUTICASONE, 1102 Cardiovascular Medicine And Haematology, Drug Administration Schedule, 03 medical and health sciences, FULFILL TRIAL, Double-Blind Method, Salmeterol/fluticasone, GLYCOPYRRONIUM, Internal medicine, Severity of illness, medicine, Humans, Adrenergic beta-2 Receptor Agonists, Indacaterol/glycopyrronium, Aged, Proportional Hazards Models, lcsh:RC705-779, Science & Technology, business.industry, Public Health, Environmental and Occupational Health, QVA149, lcsh:Diseases of the respiratory system, LABA/LAMA, medicine.disease, PREVENTION, Glycopyrrolate, 030228 respiratory system, Indacaterol, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc722fc73e1f131714a6122b66807d7Test
https://www.dovepress.com/exacerbation-heterogeneity-in-copd-subgroup-analyses-from-the-flame-st-peer-reviewed-article-COPDTest

المؤلفون: Imola Nemeth, Yavor Ivanov, Ivan Nikolaev

المصدر: International Journal of COPD, Vol Volume 13, Pp 653-663 (2018)
International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: 0301 basic medicine, Male, Time Factors, Exacerbation, Bulgarian population, Health Status, Comorbidity, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Adrenal Cortex Hormones, Risk Factors, 030212 general & internal medicine, Prospective Studies, Practice Patterns, Physicians', Bulgaria, Lung, Original Research, COPD, treatment, Remission Induction, General Medicine, Middle Aged, Obstructive lung disease, Drug Combinations, Life evaluation, Treatment Outcome, Practice Guidelines as Topic, Disease Progression, Female, Guideline Adherence, Adult, medicine.medical_specialty, Inhaled corticosteroids, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, observational, real-life, Adverse effect, Adrenergic beta-2 Receptor Agonists, Aged, lcsh:RC705-779, GOLD strategy, business.industry, lcsh:Diseases of the respiratory system, prospective, medicine.disease, 030104 developmental biology, Observational study, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9011b52e2b5472de16622e418ee7d2eTest
https://www.dovepress.com/real-life-evaluation-of-copd-treatment-in-a-bulgarian-population-a-1-y-peer-reviewed-article-COPDTest

المؤلفون: Francesco Patalano, Jadwiga A. Wedzicha, Masakazu Ichinose, Nanshan Zhong, Chau Thach, Michael Humphries, Robert Fogel, Donald Banerji

المصدر: International Journal of COPD, Vol Volume 12, Pp 339-349 (2017)
International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Vital capacity, Time Factors, Exacerbation, Health Status, Respiratory System, Vital Capacity, Quinolones, indacaterol/glycopyrronium, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, exacerbations, Forced Expiratory Volume, Surveys and Questionnaires, 030212 general & internal medicine, Lung, Original Research, Fluticasone, education.field_of_study, COPD, General Medicine, Middle Aged, Fluticasone-Salmeterol Drug Combination, Treatment Outcome, Anesthesia, Indans, Disease Progression, Female, Salmeterol, medicine.drug, medicine.medical_specialty, animal structures, Asia, Population, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, chronic obstructive pulmonary disease, 03 medical and health sciences, FEV1/FVC ratio, Asian People, Double-Blind Method, Internal medicine, medicine, Humans, education, Adrenergic beta-2 Receptor Agonists, Aged, lcsh:RC705-779, business.industry, bronchodilator agents, Recovery of Function, lcsh:Diseases of the respiratory system, biochemical phenomena, metabolism, and nutrition, medicine.disease, Glycopyrrolate, respiratory tract diseases, 030228 respiratory system, Indacaterol, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::665ea492ede1e74717193fc5a50cabfcTest
https://www.dovepress.com/indacaterolglycopyrronium-versus-salmeterolfluticasone-in-asian-patien-peer-reviewed-article-COPDTest

المؤلفون: Susan Haefliger, Yevgeniy Samyshkin, Michael Schlunegger, Sabine Ledderhose, Matthew Radford

المصدر: International Journal of COPD, Vol 2013, Iss default, Pp 79-87 (2013)
International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Cyclopropanes, Male, economic, Cost effectiveness, Cost-Benefit Analysis, Aminopyridines, Severity of Illness Index, Cohort Studies, Pulmonary Disease, Chronic Obstructive, exacerbations, Bronchodilator, health care economics and organizations, Original Research, COPD, treatment, General Medicine, Middle Aged, Markov Chains, Hospitalization, Benzamides, Disease Progression, Drug Therapy, Combination, Female, Quality-Adjusted Life Years, Models, Econometric, Switzerland, Cohort study, medicine.drug, medicine.medical_specialty, medicine.drug_class, Muscarinic Antagonists, Severe copd, International Journal of Chronic Obstructive Pulmonary Disease, Life Expectancy, Severity of illness, medicine, Humans, Intensive care medicine, cost-effectiveness, Adrenergic beta-2 Receptor Agonists, Glucocorticoids, Roflumilast, lcsh:RC705-779, business.industry, modeling, lcsh:Diseases of the respiratory system, medicine.disease, respiratory tract diseases, Quality-adjusted life year, Physical therapy, Phosphodiesterase 4 Inhibitors, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1031c73c569ac76d4c66c4d7ee35bdTest
http://www.dovepress.com/cost-effectiveness-of-roflumilast-in-combination-with-bronchodilator-t-a12090Test